Page 25 - எங்களுக்கு தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first COVID-19 Patients in Switzerland
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Moderna тестирует вакцины на детях: самому младшему шесть месяцев
ura-inform.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ura-inform.com Daily Mail and Mail on Sunday newspapers.
Researcher Under FBI Investigation for Allegedly Hiding Ties to China
A Chinese researcher who once worked at The Jackson Laboratory is under FBI investigation, for allegedly failing to disclose his financial ties to China in applications for U.S. government funding.
Ruan Yijun, a geneticist, failed to disclose his participation in a Chinese state-sponsored recruitment program called the Thousand Talents program and his collaboration agreement with China’s state-run Shenzhen People’s Hospital, according to an FBI affidavit unsealed on Mar. 2. The affidavit was filed in federal court in Bangor, Maine, on Dec. 30 last year.
The Jackson Laboratory (JAX) is a nonprofit biomedical research institution based in Maine. Its mission is to discover genetic solutions for treating human diseases. According to Ruan’s curriculum vitae (pdf) available on the JAX website, he began working at JAX’s genomics research center at the campus of the University of Connecticut Health Center in 20
Understand the long-term consequences of COVID-19: WHO
banglamirrornews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from banglamirrornews.com Daily Mail and Mail on Sunday newspapers.
InnoCare Appoints Dr. Sean Zhang as Chief Medical Officer
Search jobs InnoCare Appoints Dr. Sean Zhang as Chief Medical Officer
BEIJING (BUSINESS WIRE) InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that the Company appointed Dr. Sean Zhang as Chief Medical Officer (CMO). Reporting to the Co-founder, Chairwoman and CEO, Dr. Jasmine Cui. Dr. Zhang will be responsible for global clinical development strategy and execution for InnoCare. Dr. Zhang is based in U.S., thus demonstrating InnoCare’s ongoing commitment to globalization.
As a physician scientist, Dr. Zhang has more than 30 years working experience in clinical practice, academic research and drug discovery and development. Before joining InnoCare, Dr. Zhang served as CMO and Member of the Board of Directors of Hengrui Therapeutics Inc. (HTI) before his promotion to CEO. HTI is a joint venture between Jiangsu Hengrui Me